Circulating tumor DNA fraction correlates with residual cancer burden postneoadjuvant chemotherapy in triple negative breast cancer patients

被引:0
|
作者
Shan, Naing Lin
Gould, Billie
Blenman, Kim
Foldi, Julia
Du, Pan
Zhang, Frank
Walsh, Myles
Pusztai, Lajos
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PO5-14-05
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO5-14-05
引用
收藏
页数:3
相关论文
共 50 条
  • [21] PREDICTING RESIDUAL CANCER BURDEN IN A TRIPLE NEGATIVE BREAST CANCER COHORT
    Naylor, Peter
    Boyd, Joseph
    Lae, Marick
    Reyal, Fabien
    Walter, Thomas
    2019 IEEE 16TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2019), 2019, : 933 - 937
  • [22] Tumor mutational burden in Japanese patients with triple negative breast cancer
    Kurata, Kanako
    Kubo, Makoto
    Yuan, Yuan
    Harada, Yurina
    Morisaki, Takafumi
    Shimazaki, Akiko
    Hayashi, Saori
    Kawaji, Hitomi
    Kaneshiro, Kazuhisa
    Yamada, Mai
    Kai, Masaya
    Nakamura, Masafumi
    CANCER RESEARCH, 2020, 80 (04)
  • [23] Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy
    Clémence Pinard
    Marc Debled
    Houda Ben Rejeb
    Valérie Velasco
    Christine Tunon de Lara
    Stéphanie Hoppe
    Elodie Richard
    Véronique Brouste
    Hervé Bonnefoi
    Gaëtan MacGrogan
    Breast Cancer Research and Treatment, 2020, 179 : 11 - 23
  • [24] Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy
    Pinard, Clemence
    Debled, Marc
    Ben Rejeb, Houda
    Velasco, Valerie
    Tunon de Lara, Christine
    Hoppe, Stephanie
    Richard, Elodie
    Brouste, Veronique
    Bonnefoi, Herve
    MacGrogan, Gaetan
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (01) : 11 - 23
  • [25] Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
    Chen, Yu-Hsiang
    Hancock, Bradley A.
    Solzak, Jeffrey P.
    Brinza, Dumitru
    Scafe, Charles
    Miller, Kathy D.
    Radovich, Milan
    NPJ BREAST CANCER, 2017, 3
  • [26] Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
    Yu-Hsiang Chen
    Bradley A. Hancock
    Jeffrey P. Solzak
    Dumitru Brinza
    Charles Scafe
    Kathy D. Miller
    Milan Radovich
    npj Breast Cancer, 3
  • [27] Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study
    Haeyoung Kim
    Yeon Jeong Kim
    Donghyun Park
    Woong-Yang Park
    Doo Ho Choi
    Won Park
    Won kyung Cho
    Nalee Kim
    Breast Cancer Research and Treatment, 2021, 189 : 167 - 175
  • [28] Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study
    Kim, Haeyoung
    Kim, Yeon Jeong
    Park, Donghyun
    Park, Woong-Yang
    Choi, Doo Ho
    Park, Won
    Cho, Won Kyung
    Kim, Nalee
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (01) : 167 - 175
  • [29] High expression of pdl-1 in patients with triple negative breast cancer with residual tumor burden after neoadjuvant chemotherapy.
    Oner, Gizem
    Onder, Semen
    Karatay, Huseyin
    Tukenmez, Mustafa
    Muslumanoglu, Mahmut
    Igci, Abdullah
    Dinccag, Ahmet
    Ozmen, Vahit
    Aydiner, Adnan
    Yavuz, Ekrem
    Cabioglu, Neslihan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] The Role of Axillary Lymph Node Residual Cancer Burden in the Survival of Triple Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Khoury, Thaer
    Attwood, Kristopher
    Gandhi, Shipra
    LABORATORY INVESTIGATION, 2023, 103 (03) : S155 - S155